Cetrelimab,TAR-200,gemcitabine
Janssen
['tar200', 'gemcitabine']
the #oncoalerttoptweet day 4 of #aacr23 tweet by faculty phase1 study of a novel intravesical drug delivery system (tar200) slow release of gemcitabine in t2n0m0 showed pcr= 30%, pfs= 10 mnths. these promising data underpin the v. 
🌐 Worldwide Network of Oncology Professionals & Patient Advocates with the common goal of ending cancer, we are Oncology360 degrees 🌎 We are #OncoAlert 🚨